Pharmaceutical company Advance Healthcare Group is hoping a $10 million funding deal with Sydney firm Hawkesbridge Private Equity marks the start of its revival after a difficult three years.

Pharmaceutical company Advance Healthcare Group is hoping a $10 million funding deal with Sydney firm Hawkesbridge Private Equity marks the start of its revival after a difficult three years.